| Ytd | 4.45% | |
| 1y | -11.37% |
| Open | 16.87 | Prev Close | 17.38 | Low | 16.87 | High | 17.38 | Mkt Cap | 4.23B |
| Vol | 9.86K | Avg Vol | 9.19K | EPS | -4.60 | P/E | -3.78 | Forward P/E | -34.84 |
| Beta | 0.76 | Short Ratio | 3.94 | Inst. Own | 0.58% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-29 | 50-d Avg | 16.94 | 200-d Avg | 17.21 | 1yr Est | 53.25 |
PRTC News
BOSTON--(BUSINESS WIRE)--PureTech Health: Results of Annual General Meeting.
BOSTON--(BUSINESS WIRE)--PureTech to Showcase Deupirfenidone Program at the American Thoracic Societ
PureTech Health (LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF, FRA:0VQ) told investors that its founded entity S
PureTech Health (LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF, FRA:0VQ) told investors that its founded entity S
PureTech Health plc (PRTC) Q4 2025 Earnings Call Transcript
BOSTON--(BUSINESS WIRE)--PureTech Announces Annual Results for Year Ended December 31, 2025.
BOSTON--(BUSINESS WIRE)--PureTech Announces Intention to Voluntarily Delist American Depositary Shar
BOSTON--(BUSINESS WIRE)--PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies
BOSTON--(BUSINESS WIRE)--PureTech Reports Positive Topline Data from Phase 1b Trial of LYT-200 in R/
BOSTON--(BUSINESS WIRE)--PureTech Health: Notice of Results.
BOSTON--(BUSINESS WIRE)--PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The
PureTech Health PLC Sponsored ADR (NASDAQ: PRTC - Get Free Report) was the recipient of a large grow
BOSTON--(BUSINESS WIRE)--PureTech Founded Entity Seaport Therapeutics Announces Publication in Scien
BOSTON--(BUSINESS WIRE)--PureTech to Present at the Leerink Partners Global Healthcare Conference.
BOSTON--(BUSINESS WIRE)--PureTech Announces Orphan Drug Designations Granted by the U.S. Food and Dr
PureTech Health plc (PRTC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
BOSTON--(BUSINESS WIRE)--PureTech to Present at 44th Annual J.P. Morgan Healthcare Conference.
BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company")
PureTech Health (LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF) shares rose 4.9% to 128p on Wednesday after the c
Cavendish has taken an upbeat view of Poolbeg Pharma PLC's (AIM:POLB, OTC:POLBF) prospects after the
During Monday's trading, 1214 companies set new 52-week lows.
Thursday morning saw 168 companies set new 52-week highs.